ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,765Medicare Part D Prescriptions Filled, Including Refills

Rank: 202 out of 1456

$1.34M Total Retail Price of All Prescriptions

Rank: 52 out of 1456

550 Patients Receiving at Least One Drug in Part D
68%Patients 65 Years and Older
42% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

9% of this provider’s 550 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

3% of this provider’s 10,634 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

32% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$91 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
INSULIN SYRINGE 575 380 10 1 64
LISINOPRIL 555 411 2 3
LANTUS 502 356 3 50
METFORMIN HCL 479 319 4 8
GABAPENTIN 454 268 5 13
LEVOTHYROXINE SODIUM 428 317 6 4
OMEPRAZOLE 371 295 7 5
METFORMIN HCL ER 371 248 7 54
SIMVASTATIN 322 236 9 2
PEN NEEDLE 318 218 10 131
GLIMEPIRIDE 314 243 11 33
NOVOLOG 299 146 12 104
HYDROCHLOROTHIAZIDE 289 255 13 10
PRAVASTATIN SODIUM 281 217 14 9
LANTUS SOLOSTAR 236 120 15 120
HYDROCODONE-ACETAMINOPHEN 207 141 S3 16 6
HUMALOG 204 124 17 196
NOVOLOG FLEXPEN 192 100 18 198
ZOLPIDEM TARTRATE 192 151 18 14
CRESTOR 185 123 20 26
FUROSEMIDE 182 103 21 7
LOSARTAN POTASSIUM 182 163 21 16
CITALOPRAM HBR 174 105 23 22
SYNTHROID 172 160 24 37
POTASSIUM CHLORIDE 165 125 25 15
ATORVASTATIN CALCIUM 162 139 26 11
AMLODIPINE BESYLATE 158 108 27 1
LEVEMIR FLEXPEN 144 62 28 207
GLYBURIDE-METFORMIN HCL 127 109 R 29 119
TORSEMIDE 124 103 30 145
METOPROLOL TARTRATE 123 99 31 12
DIOVAN 117 93 32 35
METOPROLOL SUCCINATE 115 104 33 19
CLOPIDOGREL 114 107 34 32
ALLOPURINOL 108 94 35 31
TAMSULOSIN HCL 108 104 35 34
ISOSORBIDE MONONITRATE ER 108 83 35 60
LEVEMIR 99 69 38 161
HUMULIN R 93 37 39 277
WARFARIN SODIUM 92 92 40 21
FENOFIBRATE 88 70 41 56
ATENOLOL 84 61 42 18
MELOXICAM 82 66 43 30
GLIPIZIDE 81 64 44 53
GLIPIZIDE ER 80 77 45 86
NOVOLIN 70-30 80 64 45 144
BYETTA 77 35 47 281
TRICOR 77 46 47 92
VENLAFAXINE HCL ER 77 30 47 89
PLAVIX 77 71 47 46
GLYBURIDE 77 30 R 47 94
AZITHROMYCIN 75 50 52 44
TRAMADOL HCL 71 47 53 17
CHLORTHALIDONE 69 51 54 152
HUMULIN 70-30 68 29 55 205
NEXIUM 67 40 56 23
FLUTICASONE PROPIONATE 64 49 57 28
TRIAMTERENE-HCTZ 63 50 58 49
COLCRYS 59 37 59 122
DILTIAZEM ER 58 57 60 147
ACTOS 55 55 61 115
KLOR-CON M20 54 24 62 51
CYMBALTA 53 42 63 52
NOVOLOG MIX 70-30 52 39 64 204
LOSARTAN-HYDROCHLOROTHIAZIDE 52 45 64 41
DOXEPIN HCL 51 32 66 245
DILTIAZEM 24HR ER 51 35 66 126
RANITIDINE HCL 50 33 68 27
NIASPAN 50 50 68 127
DOXAZOSIN MESYLATE 50 47 68 84
POLYETHYLENE GLYCOL 3350 50 49 68 85
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 6, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.